|
⚲
|
| Keyboard |
| Mark Roth | |
|---|---|
| Firm | |
| Address | c/o Faraday Pharmaceuticals, Inc 1616 Eastlake Avenue E, Suite 560 Seattle, WA 98102 |
| Source |
| Associated Funds | Form D | Role | 2011 - 2026 | Raised | AUM |
|---|---|---|---|---|---|
| Faraday Pharmaceuticals Inc | 021-464006 | Director | 52.8 M of 102.8 M |
||
| Faraday Pharmaceuticals Inc | 021-348677 | Director | 25.1 M of 30.1 M |
||
| Faraday Pharmaceuticals Inc | 021-335158 | Director | 5.0 M of 10.0 M |
||
| Crowded Co Inc | 021-310196 | Executive Officer | 3.3 M of 3.3 M |
||
| Crowded Co Inc | 021-310201 | Executive Officer | 0.8 M of 2.8 M |
||
| Claraphi Capital LLC | 021-249892 | Executive Officer | 0.2 M of 1.0 M |
||
| Faraday Pharmaceuticals Inc | 021-221669 | Executive Officer | 32.6 M of 32.8 M |
||
| Claraphi Capital LLC | 021-194385 | Executive Officer | 0.1 M of 0.5 M |
||
| MDR Holdings LLC | 021-194379 | Executive Officer | 0.1 M of 0.5 M |
||
| Howmark Mobile Ltd Liability Co | 021-154849 | Executive Officer | 0.3 M of 0.5 M |
||